(Q37972805)

26 August 2017

title

Signaling pathways governing tumor angiogenesis (English)

1 reference

26 August 2017

1 reference

1 reference

Masatoshi Kudo

2

0 references

author name string

Toshiharu Sakurai

series ordinal

1

1 reference

26 August 2017

publication date

22 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

81 Suppl 1

1 reference

26 August 2017

page(s)

24-29

1 reference

26 August 2017

cites work

Cancer without disease.

1 reference

Clinical translation of angiogenesis inhibitors

21 January 2018

1 reference

Friends or foes - bipolar effects of the tumour stroma in cancer

21 January 2018

1 reference

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

The biology of VEGF and its receptors

21 January 2018

1 reference

Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

21 January 2018

1 reference

Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

21 January 2018

1 reference

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop.

21 January 2018

1 reference

Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies

21 January 2018

1 reference

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

21 January 2018

1 reference

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan

21 January 2018

1 reference

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

21 January 2018

1 reference

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

Molecular and physiologic mechanisms of drug resistance in cancer: an overview.

21 January 2018

1 reference

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

21 January 2018

1 reference

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

21 January 2018

1 reference

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways

21 January 2018

1 reference

The role of fibroblast growth factors in tumor growth

21 January 2018

1 reference

Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain.

21 January 2018

1 reference

Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor

21 January 2018

1 reference

Biological roles of fibroblast growth factor-2.

21 January 2018

1 reference

The FGF family: biology, pathophysiology and therapy

21 January 2018

1 reference

Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries

21 January 2018

1 reference

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice

21 January 2018

1 reference

Role of platelet-derived growth factors in physiology and medicine

21 January 2018

1 reference

Role of transforming growth factor beta in human disease

21 January 2018

1 reference

Angiogenesis in health and disease

21 January 2018

1 reference

Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system

21 January 2018

1 reference

Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas

21 January 2018

1 reference

A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models

21 January 2018

1 reference

Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth

21 January 2018

1 reference

Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2

21 January 2018

1 reference

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells

21 January 2018

1 reference

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

21 January 2018

1 reference

A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships

21 January 2018

1 reference

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

21 January 2018

1 reference

VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis

21 January 2018

1 reference

Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis

21 January 2018

1 reference

Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis

21 January 2018

1 reference

Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis

21 January 2018

1 reference

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

21 January 2018

1 reference

Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer

21 January 2018

1 reference

The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma

21 January 2018

1 reference

CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer

21 January 2018

1 reference

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice

21 January 2018

1 reference

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

21 January 2018

1 reference

Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression

21 January 2018

1 reference

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity

21 January 2018

1 reference

Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000333256

1 reference

26 August 2017

1 reference